Glaxosmithkline Pharmaceuticals Ltd logo

GLAXO

Glaxosmithkline Pharmaceuticals Ltd

₹2,369.65

Glaxosmithkline Pharmaceuticals Ltd Q2 FY2024-2025 Results: Summary

Revenue
₹1,050Cr
Net Profits
₹252.50Cr
Net Profit Margins
24.05%

Highlights

Revenue:

Glaxosmithkline Pharmaceuticals Ltd’s revenue jumped 6.58% since last year same period to ₹1,050Cr in the Q2 2024-2025. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated 23.49% jump in its revenue since last 3-months.

Net Profits:

Glaxosmithkline Pharmaceuticals Ltd’s net profit jumped 16.09% since last year same period to ₹252.50Cr in the Q2 2024-2025. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated 38.49% jump in its net profits since last 3-months.

Net Profit Margins:

Glaxosmithkline Pharmaceuticals Ltd’s net profit margin jumped 8.92% since last year same period to 24.05% in the Q2 2024-2025. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated 12.15% jump in its net profit margins since last 3-months.

FAQs

The revenue for Glaxosmithkline Pharmaceuticals Ltd in the Q2 results 2024 was ₹1,050Cr.

The net profit for Glaxosmithkline Pharmaceuticals Ltd in the Q2 results 2024 was ₹252.50Cr.

The net profit margin for Glaxosmithkline Pharmaceuticals Ltd in the Q2 results 2024 was 24.05%.

The revenue for Glaxosmithkline Pharmaceuticals Ltd in the Q2 results 2023 was ₹985.20Cr.

The net profit for Glaxosmithkline Pharmaceuticals Ltd in the Q2 results 2023 was ₹217.51Cr.

The net profit margin for Glaxosmithkline Pharmaceuticals Ltd in the Q2 results 2023 was 22.08%.